Whether advanced ovarian cancer should be treated with neoadjuvant chemotherapy or primary debulking surgery is one of the most debated topics in gynecologic oncology.
Namita Khanna, MD, MPH
Advertisement
Articles by Namita Khanna, MD, MPH
Advertisement
Latest Updated Articles
- Controversies in the Management of Advanced Ovarian Cancer
September 13th 2011
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Atezolizumab in MIBC Post-Cystectomy with ctDNA MRD
2
Sac-TMT Significantly Improves PFS/OS in Pretreated Endometrial Cancer
3
FDA Approves T-DXd in 2 Indications for HER2+ Early Breast Cancer
4
The Evolving Roles of MRD and Molecular Genotyping in Non-Hodgkin Lymphoma
5